[go: up one dir, main page]

FR2892923B1 - Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques. - Google Patents

Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.

Info

Publication number
FR2892923B1
FR2892923B1 FR0511364A FR0511364A FR2892923B1 FR 2892923 B1 FR2892923 B1 FR 2892923B1 FR 0511364 A FR0511364 A FR 0511364A FR 0511364 A FR0511364 A FR 0511364A FR 2892923 B1 FR2892923 B1 FR 2892923B1
Authority
FR
France
Prior art keywords
para
coumaric
cosmetic
acid derivatives
hydroxycinnamic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0511364A
Other languages
English (en)
Other versions
FR2892923A1 (fr
Inventor
Sabrina Okombi
Delphine Rival
Ahcene Boumendjel
Anne Marie Mariotte
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Engelhard Lyon Fr
Universite Grenoble Alpes
Original Assignee
Universite Joseph Fourier Grenoble 1
Engelhard Lyon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Joseph Fourier Grenoble 1, Engelhard Lyon SA filed Critical Universite Joseph Fourier Grenoble 1
Priority to FR0511364A priority Critical patent/FR2892923B1/fr
Priority to GB0622038A priority patent/GB2431876B/en
Priority to GB1002692A priority patent/GB2465703B/en
Priority to KR1020060109629A priority patent/KR101390061B1/ko
Priority to JP2006301831A priority patent/JP5562513B2/ja
Priority to US11/594,440 priority patent/US20070183996A1/en
Priority to DE102006052963A priority patent/DE102006052963A1/de
Priority to ES200602836A priority patent/ES2292362B1/es
Publication of FR2892923A1 publication Critical patent/FR2892923A1/fr
Application granted granted Critical
Publication of FR2892923B1 publication Critical patent/FR2892923B1/fr
Priority to US13/152,718 priority patent/US8481593B2/en
Priority to US13/913,896 priority patent/US9089499B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/10Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0511364A 2005-11-08 2005-11-08 Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques. Expired - Fee Related FR2892923B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0511364A FR2892923B1 (fr) 2005-11-08 2005-11-08 Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
GB0622038A GB2431876B (en) 2005-11-08 2006-11-06 Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
GB1002692A GB2465703B (en) 2005-11-08 2006-11-06 Cosmetic treatment using p-coumaric acid derivatives for the reduction of skin pigmentation
JP2006301831A JP5562513B2 (ja) 2005-11-08 2006-11-07 パラ−クマル酸すなわちパラ−ヒドロキシ桂皮酸誘導体類および化粧品または皮膚科組成物中でのそれらの使用
KR1020060109629A KR101390061B1 (ko) 2005-11-08 2006-11-07 파라-쿠마르산 또는 파라-히드록시신남산 유도체, 및화장용 또는 피부과용 조성물에서의 그의 용도
DE102006052963A DE102006052963A1 (de) 2005-11-08 2006-11-08 Verwendung von Derivaten der para-Cumarsäure oder para-Hydroxyzimtsäure in Kosmetika oder dermatologischen Pharmazeutika
US11/594,440 US20070183996A1 (en) 2005-11-08 2006-11-08 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions
ES200602836A ES2292362B1 (es) 2005-11-08 2006-11-08 Utilizacion de los derivados del acido para-cumarico o para-hidroxic inamico en composiciones cosmeticas o dermatologicas.
US13/152,718 US8481593B2 (en) 2005-11-08 2011-06-03 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions
US13/913,896 US9089499B2 (en) 2005-11-08 2013-06-10 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511364A FR2892923B1 (fr) 2005-11-08 2005-11-08 Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.

Publications (2)

Publication Number Publication Date
FR2892923A1 FR2892923A1 (fr) 2007-05-11
FR2892923B1 true FR2892923B1 (fr) 2009-01-16

Family

ID=36950101

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0511364A Expired - Fee Related FR2892923B1 (fr) 2005-11-08 2005-11-08 Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.

Country Status (7)

Country Link
US (3) US20070183996A1 (fr)
JP (1) JP5562513B2 (fr)
KR (1) KR101390061B1 (fr)
DE (1) DE102006052963A1 (fr)
ES (1) ES2292362B1 (fr)
FR (1) FR2892923B1 (fr)
GB (2) GB2431876B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100775095B1 (ko) * 2006-11-24 2007-11-08 (주)아모레퍼시픽 타이로졸 유도체를 함유하는 피부 미백용 화장료
KR100907685B1 (ko) * 2007-06-01 2009-07-14 게놈앤메디신(주) 노근으로부터 분리한 페놀성 화합물을 유효성분으로함유하는 피부 미백용 화장료 조성물
WO2010110353A1 (fr) * 2009-03-25 2010-09-30 味の素株式会社 Nouveau dérivé d'amide et agent de blanchiment de la peau
JP6031355B2 (ja) 2009-10-11 2016-11-24 ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー 医療装置のための生体適合性重合体
ES2369825B1 (es) * 2010-05-11 2012-10-23 Consejo Superior De Investigaciones Científicas Compuesto con actividad antioxidante.
ES2739049T3 (es) * 2010-06-30 2020-01-28 Nestle Sa Uso de ácido caftárico y derivados en suplementos alimenticios para aclarar y/o blanquear el tono de la piel
MX347326B (es) 2010-06-30 2017-04-20 L'oreal * El uso de ácido caftárico y bateria láctica en complemento alimenticio para regular la pigmentación de la piel.
BR112012032877B1 (pt) * 2010-06-30 2018-11-13 Nestec S.A. uso cosmético de ácido chicórico e derivados
PH12012502532A1 (en) * 2010-06-30 2017-08-09 Nestec Sa Use of chicoric acid and lactic bacterium in food supplement for regulating skin pigmentation
KR101221764B1 (ko) * 2010-10-05 2013-01-11 애경산업(주) 신규한 미백용 화합물
TWI454462B (zh) * 2011-01-20 2014-10-01 Li Tek Biolog Technology Company 二氫阿魏醯5-甲氧酪胺之製法
CA3069030C (fr) 2012-02-03 2021-11-16 Rutgers, The State University Of New Jersey Biomateriaux polymeres derives de monomeres phenoliques et leurs utilisations a des fins medicales
US11472918B2 (en) 2012-02-03 2022-10-18 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
FR3000488B1 (fr) * 2012-12-27 2015-10-02 Basf Beauty Care Solutions F Nouveaux derives de l'acide sinapique et leurs utilisations cosmetiques ou pharmaceutiques
EP2970585B1 (fr) 2013-03-14 2021-05-05 Case Western Reserve University Remplacements d'un précurseur de polymère de bisphénol
KR101693034B1 (ko) * 2013-04-17 2017-01-06 충북대학교 산학협력단 카페익산 유도체를 유효성분으로 포함하는 피부미백 조성물
KR101570346B1 (ko) * 2013-08-05 2015-11-20 주식회사 내추럴솔루션 N-feruloyltyramine을 함유하는 항산화, 항염증 및 주름 개선용 화장료 및 건강기능식품 조성물
US10774030B2 (en) 2014-12-23 2020-09-15 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
AU2015370426B2 (en) 2014-12-23 2019-09-12 Rutgers, The State University Of New Jersey Biocompatible iodinated diphenol monomers and polymers
WO2017123935A1 (fr) * 2016-01-13 2017-07-20 Cardelli James Allen Procédés de traitement des cancers dépendant de c-met
WO2018022016A1 (fr) * 2016-07-26 2018-02-01 Colgate-Palmolive Company Nettoyants liquides antibactérien.
CA3037678A1 (fr) 2016-10-14 2018-04-19 Universidade Do Porto Derives hydroxycinnamiques, procedes et utilisations associes
US10883089B2 (en) 2017-04-04 2021-01-05 Wisconsin Alumni Research Foundation Feruloyl-CoA:monolignol transferases
US10883090B2 (en) 2017-04-18 2021-01-05 Wisconsin Alumni Research Foundation P-coumaroyl-CoA:monolignol transferases
CA3087269A1 (fr) 2018-01-10 2019-07-18 Brightseed, Inc. Procede de modulation du metabolisme
AU2019207731B2 (en) * 2018-01-10 2024-02-08 Brightseed, Inc. Composition for modulating metabolism
CN109021035B (zh) * 2018-09-18 2021-04-06 云南中烟工业有限责任公司 一种苯乙酰胺类化合物、其制备方法和用途
WO2020097518A1 (fr) 2018-11-09 2020-05-14 Wisconsin Alumni Research Foundation Bahd acyltransférases
WO2020146635A1 (fr) * 2019-01-11 2020-07-16 Muhammed Majeed Férulates minéraux hydrosolubles et leur procédé de préparation
CA3148593A1 (fr) 2019-07-29 2021-02-04 Brightseed, Inc. Methode d'amelioration de la sante digestive
WO2021096813A1 (fr) 2019-11-11 2021-05-20 Brightseed, Inc Extrait, produit consommable et procédé d'enrichissement d'un métabolite bioactif dans un extrait
CN112094191B (zh) * 2019-12-11 2023-04-07 陕西科技大学 一种具抗氧化活性的羟基酪醇二氢咖啡酸酯及其合成方法
CA3157712C (fr) * 2020-01-01 2024-01-23 Jotiram PALKAR Compositions nutritionnelles synergiques pour ameliorer l'efficacite de l'atp cellulaire
CN111349017B (zh) * 2020-03-11 2021-07-23 中国热带农业科学院热带生物技术研究所 一种从金钗石斛中提取化合物的工艺及应用
CN111440068B (zh) * 2020-04-29 2023-08-11 陕西中医药大学 肉桂酸酯衍生物及其作为酪氨酸酶抑制剂和凝胶剂的应用
CN111978199A (zh) * 2020-08-27 2020-11-24 福州美乐莲生物科技有限公司 马齿苋酰胺及其用途
CN112843037B (zh) * 2021-01-15 2022-11-22 江南大学 一种反式4-羟基肉桂酸和阿魏酸联合抑制酪氨酸酶活性的方法
MX2023011360A (es) * 2021-04-01 2023-12-14 Mesoestetic Pharma Group S L Moleculas inhibidoras de tirosinasa y composicion dermofarmaceutica o cosmetica que las incluye.
KR102690547B1 (ko) * 2022-01-20 2024-08-01 (주)케이메디켐 N-트랜스-카페오일티라민을 포함하는 피부 미백 및 피부장벽 강화용 조성물
CN114539092B (zh) * 2022-03-14 2023-11-17 深圳海创生物科技有限公司 一种燕麦麸酚酰胺生物碱及其制备方法与在制备止痒产品中的应用
WO2024064102A1 (fr) * 2022-09-19 2024-03-28 Brightseed, Inc. Compositions et méthodes pour améliorer la perméabilité intestinale
CN116425651A (zh) * 2023-04-10 2023-07-14 云南大学 一种n-烷基酰胺类化合物制备方法及其在抗炎药物中的应用
WO2025053670A1 (fr) * 2023-09-08 2025-03-13 주식회사 테라노큐어 Composé dérivé d'acide vanillique, composition d'agent thérapeutique pour la maladie d'alzheimer le comprenant, et composition d'agent thérapeutique pour la neuro-inflammation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6020997B2 (ja) 1981-03-06 1985-05-24 日東電工株式会社 固定化酵素の製造方法
JPS57146563A (en) * 1981-03-06 1982-09-10 T Hasegawa Co Ltd Antioxidant for food and drink
JPS59196813A (ja) * 1983-04-25 1984-11-08 Kao Corp メラニン抑制剤
GB2141626B (en) 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
FR2653336B1 (fr) 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
EP0576420B1 (fr) 1991-03-21 1995-05-31 Parfums Christian Dior Nouveau derive de l'acide cafeique, l'oraposide, composition cosmetique ou pharmaceutique, notamment dermatologique le contenant
US5610185A (en) * 1995-02-17 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
US5773014A (en) * 1996-10-07 1998-06-30 Bioetica, Inc. Compositions and methods for inhibiting the formation of unwanted skin pigmentation
DE19737327A1 (de) * 1997-08-27 1999-03-04 Haarmann & Reimer Gmbh Hydroxyzimtsäureamide hydroxysubstituierter aromatischer Amine
EP1027045A4 (fr) * 1997-10-31 2004-12-08 Arch Dev Corp Procedes et compositions pour reguler l'activite de la 5-alpha-reductase
JP3590924B2 (ja) * 1998-10-27 2004-11-17 日本甜菜製糖株式会社 植物性抗酸化剤、及び、胃粘膜障害抑制剤
JP4540909B2 (ja) 1999-07-26 2010-09-08 ユニリーバー・ナームローゼ・ベンノートシヤープ 化粧品組成物中のフェルラ酸の安定化
US7078407B2 (en) * 2001-11-23 2006-07-18 Korea Research Institute Of Chemical Technology 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them
ATE320196T1 (de) * 2001-12-27 2006-04-15 Symrise Gmbh & Co Kg Verwendung von ferulasäureamiden als aromastoffe
PT1511710E (pt) * 2002-05-31 2014-02-26 Proteotech Inc Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson
FR2841550B1 (fr) 2002-06-26 2007-05-04 Sederma Sa Nouvelles molecules derivees de la tyramine, leur mode de preparation, et leur utilisation seules ou associees dans des compositions cosmetiques ou dermopharmceutiques
DK1546088T3 (en) * 2002-10-03 2015-03-30 Novaremed Ltd RELATIONSHIPS FOR USING THE TREATMENT OF AUTO-IMMUNE DISEASES, IMMUNOALLERGIC DISEASES AND ORGAN OR TISSUE TRANSPLANT AID
FR2848846B1 (fr) * 2002-12-18 2005-01-28 Oreal Utilisation cosmetique de derives de l'acide ascorbique comme agents blanchissants
US7211249B2 (en) * 2003-03-17 2007-05-01 Color Access, Inc. Heat-generating composition for topical application to skin
JP4212052B2 (ja) * 2003-10-01 2009-01-21 泰啓 満田 色素斑除去及び再発防止用皮膚外用剤
JP2005225872A (ja) * 2004-01-15 2005-08-25 National Institute Of Advanced Industrial & Technology アディポネクチン産生増進剤
KR100589352B1 (ko) * 2004-03-10 2006-06-14 학교법인조선대학교 구기자나무에서 추출한 다이하이드로-ν-카페요일티라민을함유하는 항염증용 조성물
US20070292493A1 (en) * 2006-06-15 2007-12-20 Brierre Barbara T Pharmaceutical composition and method for the transdermal delivery of calcium
JP2009040688A (ja) * 2007-08-06 2009-02-26 Tsuchida Yuzo メラニン生成抑制剤

Also Published As

Publication number Publication date
KR101390061B1 (ko) 2014-04-29
GB2431876B (en) 2010-06-09
GB2465703A (en) 2010-06-02
ES2292362A1 (es) 2008-03-01
DE102006052963A1 (de) 2007-05-16
JP2007131622A (ja) 2007-05-31
GB201002692D0 (en) 2010-04-07
JP5562513B2 (ja) 2014-07-30
FR2892923A1 (fr) 2007-05-11
GB2431876A (en) 2007-05-09
KR20070049582A (ko) 2007-05-11
US20070183996A1 (en) 2007-08-09
US9089499B2 (en) 2015-07-28
US20130272983A1 (en) 2013-10-17
GB0622038D0 (en) 2006-12-13
ES2292362B1 (es) 2009-08-07
US8481593B2 (en) 2013-07-09
GB2465703B (en) 2010-12-22
US20110237551A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
FR2892923B1 (fr) Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
EP2131848A4 (fr) Compositions et methodes de potentialisation de l'activite de molecules biologiquement actives
FR2924334B1 (fr) Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine.
MA28528B1 (fr) Derives de sulfonamide-thiazolpyridine en tant qu'activateurs de glucokinas utiles dans le traitement du diabete de type 2
WO2006103037A3 (fr) Composition contenant la $g(b)-defensine 2
EP2180786A4 (fr) Compositions antimicrobiennes à base d'acide peroxycarboxylique prêtes à l'emploi à corrosion réduite et de longue conservation
EP1639993A4 (fr) Composition de shampooing ou de nettoyage corporel
BR0313629B1 (pt) composiÇço detergente bifÁsica lÍquida aquosa de limpeza pessoal.
BRPI0820378A2 (pt) "composição aquosa pseudoplástica de cuidado pessoal e uso da dita composição".
ITRM20050332A1 (it) Uso di molecole in grado di bloccare l'attivita' di trka per potenziare gli effetti di analgesici oppiacei sul dolore.
BRPI0816038A2 (pt) "composição de tratamento dos cabelos"
EP2036565A4 (fr) Préparation pour application cutanée contenant de l'acide triterpénique
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
ITMI20020189A0 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
FR2880270B1 (fr) Composition cosmetique comprenant de l'acide ascorbique
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
EP1924684A4 (fr) Structure de l'état de transition de 5'-méthylthioadénosine/s-adénosylhomocystéine nucléosidases
EP1951709A4 (fr) Composes d imidazolidinone utiles en tant qu inhibiteurs de la beta-secretase lors du traitement de la maladie d alzheimer
FR2917086B1 (fr) Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2893501B1 (fr) Compositions topiques pour favoriser l'homeostasie de la peau
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
FR2881349B1 (fr) Nouvelle utilisation des galactomannanes en tant qu'agent actif en cosmetique.
BRPI0916080A2 (pt) "composição de limpeza pessoal líquida ou sólido-macia"
ITBO20050416A1 (it) Composizione per la cura e/o la prevenzione di attacchi da parte di agenti biologici
FR2884250B1 (fr) Utilisation des aurones pour leur activite depigmentante ou inhibitrice de la melanogenese dans des compositions cosmetiques ou dermatologiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

TQ Partial transmission of property

Owner name: UNIVERSITE GRENOBLE ALPES, FR

Effective date: 20230201

Owner name: ENGELHARD LYON, FR

Effective date: 20230201

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20250705